vs

Side-by-side financial comparison of Amarin Corp plc (AMRN) and Blend Labs, Inc. (BLND). Click either name above to swap in a different company.

Amarin Corp plc is the larger business by last-quarter revenue ($45.1M vs $32.4M, roughly 1.4× Blend Labs, Inc.). Blend Labs, Inc. runs the higher net margin — -7.8% vs -23.3%, a 15.5% gap on every dollar of revenue. On growth, Blend Labs, Inc. posted the faster year-over-year revenue change (7.6% vs 7.0%). Over the past eight quarters, Blend Labs, Inc.'s revenue compounded faster (16.6% CAGR vs -18.3%).

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.

GU Energy Labs is a company based in Berkeley, California, that produces sports nutrition products, most notably energy gels. Often consumed during endurance events, the gels are designed to be quickly and easily digested during any type of activity. Other products include energy chews, drink mixes, hydration tablets, stroopwafels and a Roctane line that includes an energy drink mix, protein recovery drink mix, gel, and capsules. The company was founded in 1994 by Bill Vaughan, who began crea...

AMRN vs BLND — Head-to-Head

Bigger by revenue
AMRN
AMRN
1.4× larger
AMRN
$45.1M
$32.4M
BLND
Growing faster (revenue YoY)
BLND
BLND
+0.6% gap
BLND
7.6%
7.0%
AMRN
Higher net margin
BLND
BLND
15.5% more per $
BLND
-7.8%
-23.3%
AMRN
Faster 2-yr revenue CAGR
BLND
BLND
Annualised
BLND
16.6%
-18.3%
AMRN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AMRN
AMRN
BLND
BLND
Revenue
$45.1M
$32.4M
Net Profit
$-10.5M
$-2.5M
Gross Margin
75.7%
Operating Margin
35.5%
-11.1%
Net Margin
-23.3%
-7.8%
Revenue YoY
7.0%
7.6%
Net Profit YoY
33.0%
-207.0%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMRN
AMRN
BLND
BLND
Q1 26
$45.1M
Q4 25
$49.2M
$32.4M
Q3 25
$49.7M
$32.7M
Q2 25
$72.7M
$31.6M
Q1 25
$42.0M
$26.8M
Q4 24
$62.3M
$30.1M
Q3 24
$42.3M
$33.1M
Q2 24
$67.5M
$28.7M
Net Profit
AMRN
AMRN
BLND
BLND
Q1 26
$-10.5M
Q4 25
$-1.2M
$-2.5M
Q3 25
$-7.7M
$12.1M
Q2 25
$-14.1M
$-6.8M
Q1 25
$-15.7M
$-9.5M
Q4 24
$-48.6M
$-825.0K
Q3 24
$-25.1M
$-2.4M
Q2 24
$1.5M
$-19.4M
Gross Margin
AMRN
AMRN
BLND
BLND
Q1 26
Q4 25
47.1%
75.7%
Q3 25
44.7%
74.3%
Q2 25
69.2%
73.8%
Q1 25
59.8%
70.8%
Q4 24
-15.4%
74.2%
Q3 24
38.5%
74.0%
Q2 24
63.4%
70.9%
Operating Margin
AMRN
AMRN
BLND
BLND
Q1 26
35.5%
Q4 25
-12.9%
-11.1%
Q3 25
-22.4%
-16.4%
Q2 25
-22.0%
-15.3%
Q1 25
-39.9%
-29.7%
Q4 24
-84.3%
-10.9%
Q3 24
-59.5%
-34.1%
Q2 24
-0.8%
-45.5%
Net Margin
AMRN
AMRN
BLND
BLND
Q1 26
-23.3%
Q4 25
-2.5%
-7.8%
Q3 25
-15.6%
37.0%
Q2 25
-19.4%
-21.6%
Q1 25
-37.4%
-35.5%
Q4 24
-78.0%
-2.7%
Q3 24
-59.4%
-7.4%
Q2 24
2.3%
-67.6%
EPS (diluted)
AMRN
AMRN
BLND
BLND
Q1 26
Q4 25
$0.00
Q3 25
$-0.02
$0.02
Q2 25
$-0.03
Q1 25
$-0.04
Q4 24
$-0.12
$-0.03
Q3 24
$-0.06
$-0.03
Q2 24
$0.00
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMRN
AMRN
BLND
BLND
Cash + ST InvestmentsLiquidity on hand
$307.8M
$68.3M
Total DebtLower is stronger
$0
Stockholders' EquityBook value
$-30.5M
Total Assets
$645.8M
$170.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMRN
AMRN
BLND
BLND
Q1 26
$307.8M
Q4 25
$302.6M
$68.3M
Q3 25
$286.6M
$77.3M
Q2 25
$298.7M
$88.3M
Q1 25
$281.8M
$104.8M
Q4 24
$294.2M
$94.2M
Q3 24
$305.7M
$112.3M
Q2 24
$306.7M
$108.9M
Total Debt
AMRN
AMRN
BLND
BLND
Q1 26
Q4 25
$0
Q3 25
$0
Q2 25
$0
Q1 25
$0
Q4 24
$0
Q3 24
$0
Q2 24
$0
Stockholders' Equity
AMRN
AMRN
BLND
BLND
Q1 26
Q4 25
$459.3M
$-30.5M
Q3 25
$458.9M
$-13.4M
Q2 25
$464.9M
$-23.1M
Q1 25
$473.7M
$-17.2M
Q4 24
$486.2M
$-56.4M
Q3 24
$531.4M
$-49.6M
Q2 24
$551.9M
$-45.5M
Total Assets
AMRN
AMRN
BLND
BLND
Q1 26
$645.8M
Q4 25
$670.8M
$170.0M
Q3 25
$659.8M
$188.6M
Q2 25
$670.1M
$182.2M
Q1 25
$655.7M
$187.5M
Q4 24
$685.3M
$178.1M
Q3 24
$750.6M
$186.1M
Q2 24
$799.9M
$185.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMRN
AMRN
BLND
BLND
Operating Cash FlowLast quarter
$1.5M
Free Cash FlowOCF − Capex
$-21.0K
FCF MarginFCF / Revenue
-0.1%
Capex IntensityCapex / Revenue
4.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-81.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMRN
AMRN
BLND
BLND
Q1 26
Q4 25
$15.3M
$1.5M
Q3 25
$-12.7M
$-3.6M
Q2 25
$16.6M
$-6.5M
Q1 25
$-12.5M
$20.1M
Q4 24
$-13.3M
$-4.6M
Q3 24
$-2.4M
$2.1M
Q2 24
$-2.7M
$-6.7M
Free Cash Flow
AMRN
AMRN
BLND
BLND
Q1 26
Q4 25
$-21.0K
Q3 25
$-5.8M
Q2 25
$-10.1M
Q1 25
$15.8M
Q4 24
$-7.1M
Q3 24
$-1.4M
Q2 24
$-8.5M
FCF Margin
AMRN
AMRN
BLND
BLND
Q1 26
Q4 25
-0.1%
Q3 25
-17.6%
Q2 25
-31.9%
Q1 25
58.9%
Q4 24
-23.5%
Q3 24
-4.1%
Q2 24
-29.7%
Capex Intensity
AMRN
AMRN
BLND
BLND
Q1 26
Q4 25
4.8%
Q3 25
6.5%
Q2 25
11.4%
Q1 25
16.1%
Q4 24
8.3%
Q3 24
10.4%
Q2 24
6.5%
Cash Conversion
AMRN
AMRN
BLND
BLND
Q1 26
Q4 25
Q3 25
-0.30×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-1.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMRN
AMRN

U.S$35.6M79%
Europe$4.9M11%
Rest-of-World (ROW)$2.8M6%
Licensing & Royalties$1.8M4%

BLND
BLND

Mortgage Suite$18.9M58%
Consumer Banking Suite$11.4M35%
Professional Services$2.1M6%

Related Comparisons